ID

15929

Description

Glucose and Lipid Metabolism on Antipsychotic Medication; ODM derived from: https://clinicaltrials.gov/show/NCT00515723

Link

https://clinicaltrials.gov/show/NCT00515723

Keywords

  1. 6/19/16 6/19/16 -
Uploaded on

June 19, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT00515723

Eligibility Schizophrenia NCT00515723

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18-60 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patients: otherwise healthy and meets dsm-iv criteria for schizophrenia or schizoaffective disorder, any type, treated with haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone for at least 3 months
Description

dsm-iv; haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone treatment

Data type

boolean

Alias
UMLS CUI [1]
C0220952
UMLS CUI [2]
C0018546
UMLS CUI [3]
C0171023
UMLS CUI [4]
C0009079
UMLS CUI [5]
C0123091
UMLS CUI [6]
C0380393
UMLS CUI [7]
C0299792
UMLS CUI [8]
C0073393
controls: healthy
Description

otherwise healthy

Data type

boolean

Alias
UMLS CUI [1]
C1708335
able to give informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
no antipsychotic medication changes for 3 months, and no other medication changes for 2 weeks prior to baseline evaluations.
Description

medication changes

Data type

boolean

Alias
UMLS CUI [1]
C0580105
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
axis i psychiatric disorder criteria met in self except for substance use disorders as below
Description

psychiatric disorder, severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0205082
patients and controls: meets dsm-iv criteria for the diagnoses of substance abuse within the past 3 months
Description

substance abuse

Data type

boolean

Alias
UMLS CUI [1]
C0038586
involuntary legal status (as per missouri law)
Description

involuntary legal status

Data type

boolean

Alias
UMLS CUI [1]
C0580275
the presence of any serious medical disorder that may confound the assessment of relevant biologic measures or diagnosis, including: significant organ system dysfunction, metabolic diseases, type 1 diabetes mellitus, symptomatic type 2 diabetes mellitus (see below), pregnancy, endocrine disease, coagulopathy, clinically significant anemia, that would preclude blood sampling (as determined by the pi) or acute infection;
Description

concomitant disease

Data type

boolean

Alias
UMLS CUI [1]
C0243087
patients taking more than one atypical antipsychotic medication;
Description

atypical antipsychotic medication

Data type

boolean

Alias
UMLS CUI [1,1]
C0748066
UMLS CUI [1,2]
C0205182
subjects taking certain prescription medications (as determined by pi on a case by case basis).
Description

prescription medications

Data type

boolean

Alias
UMLS CUI [1]
C3843193

Similar models

Eligibility Schizophrenia NCT00515723

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
aged 18-60 years
boolean
C0001779 (UMLS CUI [1])
dsm-iv; haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone treatment
Item
patients: otherwise healthy and meets dsm-iv criteria for schizophrenia or schizoaffective disorder, any type, treated with haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone for at least 3 months
boolean
C0220952 (UMLS CUI [1])
C0018546 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
C0009079 (UMLS CUI [4])
C0123091 (UMLS CUI [5])
C0380393 (UMLS CUI [6])
C0299792 (UMLS CUI [7])
C0073393 (UMLS CUI [8])
otherwise healthy
Item
controls: healthy
boolean
C1708335 (UMLS CUI [1])
informed consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
medication changes
Item
no antipsychotic medication changes for 3 months, and no other medication changes for 2 weeks prior to baseline evaluations.
boolean
C0580105 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
psychiatric disorder, severe
Item
axis i psychiatric disorder criteria met in self except for substance use disorders as below
boolean
C0004936 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
substance abuse
Item
patients and controls: meets dsm-iv criteria for the diagnoses of substance abuse within the past 3 months
boolean
C0038586 (UMLS CUI [1])
involuntary legal status
Item
involuntary legal status (as per missouri law)
boolean
C0580275 (UMLS CUI [1])
concomitant disease
Item
the presence of any serious medical disorder that may confound the assessment of relevant biologic measures or diagnosis, including: significant organ system dysfunction, metabolic diseases, type 1 diabetes mellitus, symptomatic type 2 diabetes mellitus (see below), pregnancy, endocrine disease, coagulopathy, clinically significant anemia, that would preclude blood sampling (as determined by the pi) or acute infection;
boolean
C0243087 (UMLS CUI [1])
atypical antipsychotic medication
Item
patients taking more than one atypical antipsychotic medication;
boolean
C0748066 (UMLS CUI [1,1])
C0205182 (UMLS CUI [1,2])
prescription medications
Item
subjects taking certain prescription medications (as determined by pi on a case by case basis).
boolean
C3843193 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial